All the information you need about GENSIGHT BIOLOGICS to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-10-24 | Public | 2021-12-31 | Complete |
| 2021-08-13 | Public | 2020-12-31 | Complete |
| 2020-07-22 | Public | 2019-12-31 | Complete |
| 2020-07-20 | Public | 2019-12-31 | Consolidated |
| 2019-10-28 | Public | 2018-12-31 | Complete |
| 2018-07-11 | Public | 2017-12-31 | Consolidated |
| 2018-07-09 | Public | 2017-12-31 | Complete |
| 2017-08-07 | Public | 2016-12-31 | Complete |
| Name | GENSIGHT BIOLOGICS |
| Siren | 751164757 |
| Closing | 2019-12-31 |
| Registry code | 7501 |
| Registration number | 44696 |
| Management number | 2013B05846 |
| Activity code | 7219Z |
| Closing date n-1 | 2018-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2020-07-20 |
| Modification | 01 Annual accounts entered with accounting inconsistencies at document source |
| Balance sheet type | K : Consolidated |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 75012 PARIS |
| 1 - Assets (balance sheet) | Gross amount N | Amortization year N | Net year N | Net year N-1 |
AJ Other Intangible Assets | 154 000.00 | |||
AT Other tangible assets | 4 228 000.00 | |||
BJ TOTAL (I) | 4 718 000.00 | |||
BX Customers and related accounts | 846 000.00 | |||
CJ TOTAL (II) | 27 765 000.00 | |||
CO Grand total (0 to V) | 32 483 000.00 | |||
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 821 000.00 | 620 000.00 | 821 000.00 | |
DB Share, merger, contribution premiums, etc. | 128 130 000.00 | 112 135 000.00 | 128 130 000.00 | |
DG Other reserves | -86 495 000.00 | -55 432 000.00 | -86 495 000.00 | |
DL TOTAL (I) | 11 746 000.00 | 23 870 000.00 | 11 746 000.00 | |
DN Conditional advances | 3 633 000.00 | 3 441 000.00 | 3 633 000.00 | |
DO TOTAL (II) | 3 633 000.00 | 3 441 000.00 | 3 633 000.00 | |
DR TOTAL (IV) | 103 000.00 | 65 000.00 | 103 000.00 | |
DX Trade payables and related accounts | 7 139 000.00 | 7 593 000.00 | 7 139 000.00 | |
EC TOTAL (IV) | 10 506 000.00 | 9 602 000.00 | 10 506 000.00 | |
EE Grand total (I to V) | 32 483 000.00 | 36 979 000.00 | 32 483 000.00 | |
P2 LIABILITIES - Gross Technical Reserves | -30 710 000.00 | -33 453 000.00 | -30 710 000.00 | |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FJ Net sales | 700 000.00 | |||
FR Total operating income (I) | 4 910 000.00 | |||
GF Total Operating Expenses (II) | 35 208 000.00 | |||
GG - OPERATING RESULT (I - II) | -30 298 000.00 | |||
GP Total financial income (V) | 95 000.00 | |||
GU Total financial expenses (VI) | 504 000.00 | |||
GV - FINANCIAL INCOME (V - VI) | -409 000.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | -30 707 000.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HK Income tax | -4 000.00 | -4 000.00 | ||
R6 Group Income (Consolidated Net Income) | -30 710 000.00 | -33 453 000.00 | -30 710 000.00 | |
